| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5290961 | SANOFI AVENTIS US | Platinum compound and process of preparing same |
Jan, 2013
(11 years ago) | |
| US5338874 | SANOFI AVENTIS US | Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
Apr, 2013
(11 years ago) | |
|
US5290961 (Pediatric) | SANOFI AVENTIS US | Platinum compound and process of preparing same |
Jul, 2013
(10 years ago) | |
|
US5338874 (Pediatric) | SANOFI AVENTIS US | Cis oxalato (trans 1-1,2-cyclohexanediamine) PT(II) having optically high purity |
Oct, 2013
(10 years ago) | |
| US5716988 | SANOFI AVENTIS US | Pharmaceutically stable preparation of oxaliplatinum |
Aug, 2015
(8 years ago) | |
|
US5716988 (Pediatric) | SANOFI AVENTIS US | Pharmaceutically stable preparation of oxaliplatinum |
Feb, 2016
(8 years ago) | |
| US5420319 | SANOFI AVENTIS US | Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
Aug, 2016
(7 years ago) | |
|
US5420319 (Pediatric) | SANOFI AVENTIS US | Cis-oxalato(trans-1-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same |
Feb, 2017
(7 years ago) | |
Eloxatin is owned by Sanofi Aventis Us.
Eloxatin contains Oxaliplatin.
Eloxatin has a total of 8 drug patents out of which 8 drug patents have expired.
Expired drug patents of Eloxatin are:
- US5290961
- US5338874
- US5290961*PED
- US5338874*PED
- US5716988
- US5716988*PED
- US5420319
- US5420319*PED
Eloxatin was authorised for market use on 09 August, 2002.
Eloxatin is available in injectable;intravenous dosage forms.
The generics of Eloxatin are possible to be released after 09 February, 2017.
Drugs and Companies using OXALIPLATIN ingredient
Market Authorisation Date: 09 August, 2002
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS
How can I launch a generic of ELOXATIN before it's drug patent expiration?
More Information on Dosage
ELOXATIN family patents
